Medscape covers CHEST 2015, where the treatment of central sleep apnea in heart failure patients was in the spotlight.

“I do think a lot of good has come out of this trial because now at least we have the best data to show that what we thought was beneficial is actually harmful,” said panel chair Neil Freedman, MD, from Northshore University Health System in Bannockburn, Illinois.

The current recommendation from the American Academy of Sleep Medicine (AASM) is to “not start anybody on adaptive servo ventilation who would have qualified for this trial,” Dr Freedman told Medscape Medical News.